FDA asks infant formula makers to strengthen safeguards after botulism
United States Public Health and Disease Watch – On July 13, FDA asked formula makers for stronger supplier oversight after botulism cases; CDC shares safer prep steps.
Infant Health
-
-
CDC/FDA July 6 update: Infant botulism cases linked to recalled Nara formula
July 6 federal update: CDC and FDA report 4 infant botulism cases linked to recalled Nara powdered formula. Stop using it and watch symptoms.